Metoprolol Succinate Tablet, Extended Release
Product Images NDC 71205-162

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 71205-162). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

71205-162-90 (50mg)

METOPROLOL SUCCINATE 50 mg extended-release tablets label by Proficient Rx LP. Contains 90 tablets per bottle. Each white, round, biconvex, film-coated tablet is engraved with 'A over mo' on one side and scored on the other. Manufactured by AstraZeneca AB, Sweden. Storage instructions and lot/expiration placeholders are included.*

FDA Label Image

Structuralformula (Image 01)

Chemical structure diagram of Metoprolol succinate showing its molecular components including the metoprolol moiety and succinate moiety. The structure details atoms and bonds in the extended formula representation.*

FDA Label Image

Merit Graphic (Image 02)

A forest plot chart titled 'Results for Subgroups in MERIT-HF' comparing relative risk and 95% confidence intervals for metoprolol succinate extended release tablets versus placebo across various patient subgroups. The chart includes three outcome measures: Total Mortality, Total Mortality or All-Cause Hospitalization (Time to First Event), and Total Mortality or Hospitalization for Heart Failure (Time to First Event). Subgroups listed include geographic locations, NYHA classes, ejection fraction levels, etiology, sex, race, prior medical history, diabetes status, hypertension status, and heart rate categories.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.